Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/bcar1-expression-improves-prediction-of-biochemical-reccurence-after-L63PkdA90O
References (41)
-
G. Carruba (2007)
Estrogen and prostate cancer: An eclipsed truth in an androgen‐dominated scenarioJournal of Cellular Biochemistry, 102
-
G. Swanson, J. Basler (2010)
Prognostic Factors for Failure after ProstatectomyJournal of Cancer, 2
-
Misop Han, A. Partin, M. Zahurak, S. Piantadosi, J. Epstein, P. Walsh (2003)
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.The Journal of urology, 169 2
-
G. Lughezzani, A. Briganti, P. Karakiewicz, M. Kattan, F. Montorsi, S. Shariat, A. Vickers (2010)
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.European urology, 58 5
-
J. Walz, F. Chun, E. Klein, Alwyn Reuther, F. Saad, M. Graefen, H. Huland, P. Karakiewicz (2009)
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.The Journal of urology, 181 2
-
M. Helms, D. Kemming, H. Pospisil, U. Vogt, H. Buerger, E. Korsching, C. Liedtke, C. Liedtke, C. Schlotter, Alice Wang, S. Chan, B. Brandt (2008)
Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II diseaseBritish Journal of Cancer, 99
-
N. Tsuchiya, Lizhong Wang, Hiroyoshi Suzuki, T. Segawa, Hisami Fukuda, S. Narita, M. Shimbo, T. Kamoto, K. Mitsumori, T. Ichikawa, O. Ogawa, A. Nakamura, T. Habuchi (2006)
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 13
-
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)
Global Cancer Statistics -
BCAR 1 expression in -
Rile Li, T. Wheeler, Hong Dai, A. Frolov, T. Thompson, G. Ayala (2004)
High Level of Androgen Receptor Is Associated With Aggressive Clinicopathologic Features and Decreased Biochemical Recurrence-free Survival in Prostate: Cancer Patients Treated With Radical ProstatectomyThe American Journal of Surgical Pathology, 28
-
K. Wako, T. Kawasaki, K. Yamana, Kazuya Suzuki, Shuying Jiang, H. Umezu, T. Nishiyama, Kota Takahashi, T. Hamakubo, T. Kodama, M. Naito (2007)
Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancerJournal of Clinical Pathology, 61
-
T. Sissung, R. Danesi, C. Kirkland, Caitlin Baum, Sandra Ockers, E. Stein, D. Venzon, D. Price, W. Figg (2011)
Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy.The Journal of clinical endocrinology and metabolism, 96 2
-
S. Minner, Birte Jessen, Lars Stiedenroth, E. Burandt, J. Köllermann, M. Mirlacher, A. Erbersdobler, C. Eichelberg, M. Fisch, T. Brümmendorf, C. Bokemeyer, R. Simon, T. Steuber, M. Graefen, H. Huland, G. Sauter, T. Schlomm (2010)
Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate CancerClinical Cancer Research, 16
-
A. Lopergolo, N. Zaffaroni (2009)
Biomolecular markers of outcome prediction in prostate cancerCancer, 115
-
O. Celhay, M. Yacoub, J. Irani, B. Doré, O. Cussenot, G. Fromont (2010)
Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression.The Journal of urology, 184 5
-
W. Lowrance, P. Scardino (2009)
Predictive models for newly diagnosed prostate cancer patients.Reviews in urology, 11 3
-
M. Uemura, K. Tamura, Suyoun Chung, S. Honma, A. Okuyama, Yusuke Nakamura, H. Nakagawa (2007)
Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancerCancer Science, 99
-
S. Freedland, E. Humphreys, L. Mangold, M. Eisenberger, F. Dorey, P. Walsh, A. Partin (2005)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.JAMA, 294 4
-
T. Sissung, R. Danesi, C. Kirkland, Caitlin Baum, Sandra Ockers, E. Stein, D. Venzon, D. Price, W. Figg (2011)
Estrogen Receptor α and Aromatase Polymorphisms Affect Risk, Prognosis, and Therapeutic Outcome in Men with Castration-Resistant Prostate Cancer Treated with Docetaxel-Based TherapyMolecular Endocrinology, 25
-
S. Shikanov, Jie Song, C. Royce, H. Al-Ahmadie, K. Zorn, G. Steinberg, G. Zagaja, A. Shalhav, S. Eggener (2009)
Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.The Journal of urology, 182 1
-
G. Fromont, G. Vallancien, P. Validire, P. Levillain, O. Cussenot (2007)
BCAR1 expression in prostate cancer: Association with 16q23 LOH status, tumor progression and EGFR/KAI1 stainingThe Prostate, 67
-
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, D. Forman (2011)
Global cancer statisticsCA: A Cancer Journal for Clinicians, 61
-
M. Donovan, S. Hamann, M. Clayton, F. Khan, M. Sapir, V. Bayer-Zubek, G. Fernandez, R. Mesa-Tejada, M. Teverovskiy, V. Reuter, P. Scardino, C. Cordon-Cardo (2008)
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 24
-
I. Leav, K. Lau, J. Adams, J. McNeal, M. Taplin, J. Wang, H. Singh, S. Ho (2001)
Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.The American journal of pathology, 159 1
-
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
-
Freedland (2005)
Risk of cancer specific mortality following biochemical recurrence after radical prostatectomyJAMA, 294
-
G. Fromont, P. Validire, D. Prapotnich, F. Rozet, G. Vallancien, O. Cussenot, X. Cathelineau (2010)
Pathologic Reassessment of Prostate Cancer Surgical Specimens Before Molecular Retrospective StudiesClinical Cancer Research, 17
-
L. Dorssers, N. Grebenchtchikov, A. Brinkman, M. Look, Simone Broekhoven, D. Jong, H. Peters, H. Portengen, M. Gelder, J. Klijn, Doorlene Tienoven, A. Geurts-Moespot, P. Span, J. Foekens, F. Sweep (2004)
The Prognostic Value of BCAR1 in Patients with Primary Breast CancerClinical Cancer Research, 10
-
S. Flier, Christina Chan, A. Brinkman, M. Smid, S. Johnston, L. Dorssers, M. Dowsett (2000)
BCAR1/p130Cas expression in untreated and acquired tamoxifen‐resistant human breast carcinomasInternational Journal of Cancer, 89
-
L. Thomas, R. Douglas, C. Lazier, C. Too, R. Rittmaster, D. Tindall (2008)
Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate CancerEuropean Urology, 53
-
I. Leav, K. Lau, J. Adams, J. McNeal, M. Taplin, Jianfu Wang, Hema Singh, S. Ho (2001)
Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic CarcinomaAmerican Journal of Pathology, 159
-
S. Cabodi, L. Moro, G. Baj, M. Smeriglio, P. Stefano, S. Gippone, N. Surico, L. Silengo, E. Turco, G. Tarone, P. Defilippi (2004)
p130Cas interacts with estrogen receptor α and modulates non-genomic estrogen signaling in breast cancer cellsJournal of Cell Science, 117
-
G. Fromont, M. Yacoub, A. Valéri, P. Mangin, G. Vallancien, G. Cancel-Tassin, O. Cussenot (2008)
Differential Expression of Genes Related to Androgen and Estrogen Metabolism in Hereditary versus Sporadic Prostate CancerCancer Epidemiology Biomarkers & Prevention, 17
-
H. Bonkhoff, R. Berges (2009)
The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.European urology, 55 3
-
O. Cussenot, A. Azzouzi, N. Nicolaiew, G. Fromont, P. Mangin, L. Cormier, G. Fournier, A. Valéri, S. Larré, F. Thibault, J. Giordanella, M. Pouchard, Yan Zheng, F. Hamdy, A. Cox, G. Cancel-Tassin (2007)
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 24
-
S. Cabodi, M. Camacho-Leal, P. Stefano, P. Defilippi (2010)
Integrin signalling adaptors: not only figurants in the cancer storyNature Reviews Cancer, 10
-
A. Jemal, R. Siegel, Jiaquan Xu, Elizabeth Ward (2010)
Cancer Statistics, 2010CA: A Cancer Journal for Clinicians, 60
-
E. Folkerd, M. Dowsett (2010)
Influence of sex hormones on cancer progression.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 26
-
Michael Stanbrough, G. Bubley, K. Ross, T. Golub, M. Rubin, T. Penning, P. Febbo, S. Balk (2006)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.Cancer research, 66 5
-
L. Thomas, R. Douglas, C. Lazier, C. Too, R. Rittmaster, D. Tindall (2008)
Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.European urology, 53 2
-
S. Ellem, J. Schmitt, J. Pedersen, M. Frydenberg, G. Risbridger (2004)
Local aromatase expression in human prostate is altered in malignancy.The Journal of clinical endocrinology and metabolism, 89 5
- Publisher
- Wiley
- Copyright
- Copyright © 2012 Wiley Subscription Services
- ISSN
- 0270-4137
- eISSN
- 1097-0045
- DOI
- 10.1002/pros.22485
- pmid
- 22241677
- Publisher site
- See Article on Publisher Site
Abstract
Journal
The Prostate – Wiley
Published: Jan 1, 2012
Keywords: ; ; ;